AzTrials
AzTrials

Postpartum PainNCT07471724

Skin-to-Skin Contact, Cheek Contact and Episiotomy Pain Control

A study testing Skin-to-Skin Contact and Cheek-to-Cheek Contact in people with Postpartum Pain and Episiotomy Pain, run by Ege University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial aimed to evaluate the effects of skin-to-skin contact and kangaroo care on pain control during and after episiotomy repair following vaginal birth. Read more about this study

Who is it for?
Ages 18 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Postpartum Pain, Episiotomy Pain, Postpartum Care
What is being tested?
Skin-to-Skin Contact and Cheek-to-Cheek Contact
Could I receive a placebo?
No, everyone receives an active treatment
How many people
155 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Apr 2024to 25 Nov 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Women aged 18 years or older
  • Able to speak and understand Turkish
  • Singleton pregnancy at ≥37 gestational weeks
  • Spontaneous vaginal birth with mediolateral episiotomy
  • Mother and newborn clinically stable after birth
  • Newborn APGAR score ≥7 at 1 and 5 minutes
  • Willingness to participate and provision of informed consent

Who cannot join

  • Operative vaginal birth (vacuum or forceps)
  • Third- or fourth-degree perineal tear or extensive perineal laceration
  • Epidural analgesia during labor
  • Maternal or neonatal complications requiring medical intervention
  • Conditions requiring maternal-infant separation after birth
  • Refusal to participate in the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ege University

    Izmir, İmbatlı Mah, 35400

Other trials in Turkey (Türkiye)

About this study

Official title: COMPARISON OF THE EFFECTS OF SKIN-TO-SKIN CONTACT, CHEEK CONTACT AND ROUTINE CARE ON PAIN CONTROL FOLLOWING EPISIOTOMY REPAIR: A RANDOMISED CONTROLLED TRIAL

This randomized controlled trial aimed to evaluate the effects of skin-to-skin contact and kangaroo care on pain control during and after episiotomy repair following vaginal birth. The study was conducted at Izmir Bakircay University Cigli Regional Training and Research Hospital and included 155 healthy women who had spontaneous vaginal birth and healthy newborns. Participants were randomly assigned to three groups: kangaroo care (n=50), cheek-to-cheek contact (n=50), and standard postpartum care (n=55). Pain levels were assessed after episiotomy repair and at the 6th and 12th hours postpartum using the Verbal Rating Scale. Secondary outcomes included breastfeeding frequency and maternal satisfaction. The results indicate that kangaroo care and cheek-to-cheek contact may reduce postpartum episiotomy pain and improve breastfeeding outcomes, supporting their integration into routine maternity care.

Read the detailed description

This randomized controlled experimental study was conducted at Izmir Bakircay University Cigli Regional Training and Research Hospital in Türkiye. A total of 155 healthy women who had spontaneous vaginal birth at term (≥37 weeks) and their healthy newborns were included. Eligible participants were aged 18 years and older, had no medical complications, and had newborns with Apgar scores ≥7 at 1 and 5 minutes. Participants were recruited during active labour and randomly assigned to three groups: kangaroo care group (skin-to-skin contact, n=50), cheek-to-cheek contact group (n=50), and control group receiving standard postpartum care (n=55). Randomization was performed using a computer-generated random number sequence, with allocation concealed in sealed, opaque envelopes. The kangaroo care group received immediate skin-to-skin contact between mother and newborn. The cheek-to-cheek contact group received structured cheek-to-cheek contact. The control group received routine postpartum care according to hospital protocols. Primary outcomes included pain levels assessed after episiotomy repair and at the 6th and 12th hours postpartum using the Verbal Rating Scale. Secondary outcomes included breastfeeding frequency, amount of local anesthesia used, and maternal satisfaction. Data were collected using structured questionnaires on sociodemographic and obstetric characteristics. Statistical analyses were performed using descriptive statistics, chi-square tests, one-way ANOVA, and Bonferroni post-hoc tests. All participants provided written informed consent prior to participation. The study was approved by the Izmir Bakircay University Non-Interventional Clinical Research Ethics Committee and conducted in accordance with the Declaration of Helsinki.

Being tested
Skin-to-Skin Contact, Cheek-to-Cheek Contact
Keywords
Kangaroo care, skin to skin contact, Cheek Contact, Vaginal Birth, Postpartum Pain Management, Episiotomy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Skin-to-Skin ContactBehavioural

    Immediately after vaginal birth and during episiotomy repair, the newborn was placed prone on the mother's bare chest to provide continuous skin-to-skin contact. The infant was positioned in an upright and safe posture and covered with a blanket when necessary. The intervention was maintained according to the study protocol and supervised by trained midwives.

  • Cheek-to-Cheek ContactBehavioural

    During and after episiotomy repair, structured cheek-to-cheek contact was established between the mother and the newborn. The infant's cheek was gently placed in contact with the mother's cheek in a comfortable position. The procedure was applied according to standardized instructions and supervised by trained staff.

Study groups in NCT07471724
Study groupRoleWhat they receive
Skin-to-Skin ContactExperimentalParticipants in this group received immediate skin-to-skin contact between the mother and newborn following vaginal birth. The newborn was placed prone on the mother's bare chest during and after episiotomy repair and maintained according to the study protocol.
Receives: Behavioral: Skin-to-Skin Contact; Behavioral: Cheek-to-Cheek Contact
Cheek-to-Cheek ContactExperimentalParticipants in this group received structured cheek-to-cheek contact between the mother and newborn during and after episiotomy repair. The intervention was applied according to standardized procedures defined in the study protocol.
Receives: Behavioral: Skin-to-Skin Contact; Behavioral: Cheek-to-Cheek Contact
Standart care groupOtherParticipants in this group received routine postpartum care according to hospital protocols, without additional skin-to-skin or cheek-to-cheek contact interventions.
Receives: Behavioral: Skin-to-Skin Contact; Behavioral: Cheek-to-Cheek Contact

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Episiotomy pain intensity (Numeric Rating Scale)

    Maternal pain intensity related to episiotomy repair measured using a 0-10 Numeric Rating Scale (NRS), where 0 indicates no pain and 10 indicates worst possible pain. Pain scores were self-reported by mothers during follow-up assessments.

    Measured: Immediately after episiotomy repair, at 6 hours postpartum, and at 12 hours postpartum

Secondary outcomes (2)
  1. Breastfeeding frequency

    Number of breastfeeding episodes during early postpartum period

    Measured: Within first 12 hours postpartum

  2. Newborn APGAR scores

    APGAR scores at 1 and 5 minutes after birth

    Measured: 1st and 5th minute after birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2026
  2. Study start1 Apr 2024
  3. Primary completion20 Nov 2024
  4. Study completion25 Nov 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study was designed as a three-arm, parallel-group randomized controlled trial. Eligible participants were randomly assigned during active labour to receive kangaroo care, cheek-to-cheek contact, or standard postpartum care. Outcomes were assessed after episiotomy repair and during the early postpartum period.
Masking
None (open label)
Enrolment
155 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07471724
Sponsor's protocol ID
EGE-SKINTOSKIN-2024
Other IDs
Decision No:906
Status last verified
Mar 2026
First submitted
10 Mar 2026
Last updated
13 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The investigators have not yet made a final decision regarding sharing individual participant data (IPD). Data sharing may be considered in the future upon reasonable request, following institutional policies, ethical approval conditions, and protection of participant confidentiality.

Questions about this trial

What is this clinical trial studying?

A study testing Skin-to-Skin Contact and Cheek-to-Cheek Contact in people with Postpartum Pain and Episiotomy Pain, run by Ege University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Episiotomy pain intensity (Numeric Rating Scale) (time frame: Immediately after episiotomy repair, at 6 hours postpartum, and at 12 hours postpartum). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in